Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
01-May-24 | Sell | Arvind Balan | 151.00p | 633,785 | £957,015.34 |
03-Apr-24 | Buy | Ken Gilmartin | 128.70p | 278,178 | £358,015.07 |
04-Apr-24 | Buy | Ken Gilmartin | 132.80p | 150,000 | £199,199.99 |
22-Aug-23 | Buy | Susan Steele | 156.28p | 13,000 | £20,316.01 |
03-Apr-24 | Buy | Susan Steele | 130.41p | 15,413 | £20,100.10 |
12-Jun-23 | Sell | David Kemp | 135.00p | 14,883 | £20,092.05 |
14-Mar-24 | Buy | Ken Gilmartin | 144.00p | 4,640 | £6,681.60 |
18-Apr-24 | Buy | Ken Gilmartin | 150.00p | 4,439 | £6,658.50 |
14-Dec-23 | Buy | Ken Gilmartin | 152.00p | 4,220 | £6,414.40 |
21-Sep-23 | Buy | Ken Gilmartin | 160.00p | 4,007 | £6,411.20 |
20-Jul-23 | Buy | Ken Gilmartin | 145.00p | 4,418 | £6,406.10 |
18-Jan-24 | Buy | Ken Gilmartin | 168.00p | 3,812 | £6,404.16 |
16-Nov-23 | Buy | Ken Gilmartin | 148.00p | 4,326 | £6,402.48 |
15-Jun-23 | Buy | Ken Gilmartin | 130.00p | 4,924 | £6,401.20 |
17-Aug-23 | Buy | Ken Gilmartin | 155.00p | 4,129 | £6,399.95 |
21-Sep-23 | Buy | David Kemp | 160.00p | 2,635 | £4,216.00 |
20-Jul-23 | Buy | David Kemp | 145.00p | 2,905 | £4,212.25 |
17-Aug-23 | Buy | David Kemp | 155.00p | 2,715 | £4,208.25 |
15-Jun-23 | Buy | David Kemp | 130.00p | 3,237 | £4,208.10 |
28-Jun-23 | Buy | Jacqui Ferguson | 131.00p | 2,503 | £3,278.93 |
Currency | UK Pounds |
Share Price | 183.30p |
Change Today | -4.10p |
% Change | -2.19 % |
52 Week High | 200.60 |
52 Week Low | 125.70 |
Volume | 193,733 |
Shares Issued | 691.84m |
Market Cap | £1,268.14m |
RiskGrade | 236 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 5 |
Buy | 0 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 29-Aug-19 | 25-Apr-19 |
Paid | 26-Sep-19 | 16-May-19 |
Amount | 11.40¢ | 23.70¢ |
Time | Volume / Share Price |
09:36 | 1,000 @ 183.35p |
09:33 | 200 @ 183.30p |
09:33 | 25 @ 183.20p |
09:33 | 2,200 @ 183.30p |
09:33 | 500 @ 183.50p |
Chair | Roy Franklin |
CEO | Ken Gilmartin |
CFO | Arvind Balan |
You are here: research